Atlas Trials

First-in-Human Study Testing a New Antibody Treatment for Tick-Borne Encephalitis in Healthy Volunteers.

Clinical trial NCT07377253 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07377253
Sponsor
Giuseppe Pantaleo
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
The Tick-borne Encephalitis Virus (TBEV)
Start date
2026-01-01
Primary completion
2026-05-31
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.